Search research articles
Contact Us
Filters
Showing results (31-40 of 104) with videos related to
Page
of 11
Sort By:
Hemasphere
|
July 4, 2024
Stage-adapted treatment of HIV-associated Hodgkin lymphoma: Long-term results of a prospective, multicenter study
Marcus Hentrich, Markus Müller, Christoph Wyen, et al.
British Journal of Haematology
|
May 7, 2021
Characteristics and outcome of human immunodeficiency virus (HIV)-associated primary effusion lymphoma as observed in the German HIV-related lymphoma cohort study
Marcus Hentrich, Markus Müller, Christoph Wyen, et al.
Annals of Hematology
|
July 22, 2015
Antiviral prophylaxis in patients with solid tumours and haematological malignancies--update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)
Michael Sandherr, Marcus Hentrich, Marie von Lilienfeld-Toal, et al.
Annals of Hematology
|
August 17, 2022
Scheduled removal of central venous catheters (CVC) to prevent CVC-related bloodstream infections in patients with hematological disease or autologous stem cell transplantation: a registry-based randomized simulation-study
Jens Panse, Daniela Tölle, Eva Fiegle, et al.
Journal of Cancer Research and Clinical Oncology
|
September 21, 2018
Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group
Martin Fenner, Christoph Oing, Annette Dieing, et al.
Virchows Archiv : an International Journal of Pathology
|
December 14, 2023
Molecular and histopathological characterization of seminoma patients with highly elevated human chorionic gonadotropin levels in the serum
Christoph Seidel, Finn-Ole Paulsen, Tim Nestler, et al.
Infection Control and Hospital Epidemiology
|
December 11, 2019
Central venous catheter-related bloodstream infections in patients with hematological malignancies: Comparison of data from a clinical registry and a randomized controlled trial
Enrico Schalk, Daniel Teschner, Marcus Hentrich, et al.
Critical Care Medicine
|
March 17, 2006
IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial
Marcus Hentrich, Karl Fehnle, Helmut Ostermann, et al.
British Journal of Haematology
|
August 26, 2022
Central venous catheter-related bloodstream infections in patients with haematological malignancies during the SARS-CoV-2 pandemic
Enrico Schalk, Timo Schmitt, Jens Panse, et al.
Infection
|
April 4, 2023
Impact of the insertion site of central venous catheters on central venous catheter-related bloodstream infections in patients with cancer: results from a large prospective registry
Marcus Hentrich, Boris Böll, Daniel Teschner, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 104) with videos related to
Sort By:
Page
of 11
Hemasphere
|
July 4, 2024
Stage-adapted treatment of HIV-associated Hodgkin lymphoma: Long-term results of a prospective, multicenter study
Marcus Hentrich, Markus Müller, Christoph Wyen, et al.
British Journal of Haematology
|
May 7, 2021
Characteristics and outcome of human immunodeficiency virus (HIV)-associated primary effusion lymphoma as observed in the German HIV-related lymphoma cohort study
Marcus Hentrich, Markus Müller, Christoph Wyen, et al.
Annals of Hematology
|
July 22, 2015
Antiviral prophylaxis in patients with solid tumours and haematological malignancies--update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)
Michael Sandherr, Marcus Hentrich, Marie von Lilienfeld-Toal, et al.
Annals of Hematology
|
August 17, 2022
Scheduled removal of central venous catheters (CVC) to prevent CVC-related bloodstream infections in patients with hematological disease or autologous stem cell transplantation: a registry-based randomized simulation-study
Jens Panse, Daniela Tölle, Eva Fiegle, et al.
Journal of Cancer Research and Clinical Oncology
|
September 21, 2018
Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group
Martin Fenner, Christoph Oing, Annette Dieing, et al.
Virchows Archiv : an International Journal of Pathology
|
December 14, 2023
Molecular and histopathological characterization of seminoma patients with highly elevated human chorionic gonadotropin levels in the serum
Christoph Seidel, Finn-Ole Paulsen, Tim Nestler, et al.
Infection Control and Hospital Epidemiology
|
December 11, 2019
Central venous catheter-related bloodstream infections in patients with hematological malignancies: Comparison of data from a clinical registry and a randomized controlled trial
Enrico Schalk, Daniel Teschner, Marcus Hentrich, et al.
Critical Care Medicine
|
March 17, 2006
IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial
Marcus Hentrich, Karl Fehnle, Helmut Ostermann, et al.
British Journal of Haematology
|
August 26, 2022
Central venous catheter-related bloodstream infections in patients with haematological malignancies during the SARS-CoV-2 pandemic
Enrico Schalk, Timo Schmitt, Jens Panse, et al.
Infection
|
April 4, 2023
Impact of the insertion site of central venous catheters on central venous catheter-related bloodstream infections in patients with cancer: results from a large prospective registry
Marcus Hentrich, Boris Böll, Daniel Teschner, et al.
Page
of 11